4//SEC Filing
Shams Aammaad 4
Accession 0001628908-22-000037
CIK 0001628908other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:28 PM ET
Size
6.7 KB
Accession
0001628908-22-000037
Insider Transaction Report
Form 4
Shams Aammaad
Chief Accounting Officer
Transactions
- Award
Class A Common Stock
2022-03-01+6,250→ 21,250 total - Tax Payment
Class A Common Stock
2022-03-01$27.40/sh−1,613$44,196→ 19,637 total
Footnotes (4)
- [F1]Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F2]Securities vest at a rate of 34% on March 1, 2023, and 33 % on March 1, 2024, and March 1, 2025.
- [F3]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F4]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001815354
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 9:28 PM ET
- Size
- 6.7 KB